Revvity | PKI - Net Income


Revvity reported $40.72M in Net Income for its fiscal quarter ending in March of 2026.





Net Income Change Date
Agilent USD 339M 34M Mar/2026
Align Technology USD 112.77M 22.99M Mar/2026
Bio Techne USD 51.05M 13.04M Mar/2026
Bio-Rad Laboratories USD 720M 1.06B Dec/2025
Bruker USD 3.5M 22.5M Mar/2026
Celltrion KRW 8.82B 64.74M Mar/2026
Charles River Laboratories USD -14.84M 261.71M Mar/2026
Cspc Pharmaceutical CNY 370.72M 592.81M Dec/2025
Danaher USD 870M 159M Jun/2026
Dentsply International USD -10M 136M Mar/2026
Deva Holding AS TRY 583.98M 319.1M Sep/2023
Dianthus Therapeutics USD -40.83M 23.6M Mar/2026
Divis Laboratories Ltd INR 7.51B 1.68B Mar/2026
Edwards Lifesciences USD 241.9M 138.8M Jun/2026
Illumina USD 134M 200M Mar/2026
Intuitive Surgical USD 818.1M 3.4M Jun/2026
IQVIA Holdings USD 274M 240M Mar/2026
Kangmei Pharma CNY -16.56M 12.74M Mar/2026
Knight Therapeutics CAD -3.79M 8.83M Sep/2025
Laboratorios Farma EUR 103.69M 37.04M Dec/2023
Laboratory Of America USD 277.8M 113.1M Mar/2026
Malin Corporation EUR -1.1M 2.2M Dec/2023
Medical Developments International AUD -226K 121K Dec/2025
Mesa Laboratories USD -1.68M 5.1M Dec/2024
Mettler Toledo International USD 169.45M 116.31M Mar/2026
Myriad Genetics USD -7.9M 19.5M Dec/2025
Neuren Pharmaceuticals AUD 15.4M 7.88M Dec/2025
OraSure Technologies USD -19.29M 5.57M Dec/2025
Organigram Holdings CAD -921K 20.89M Mar/2026
Ovoca Bio EUR -765K 4.89M Jun/2025
Pacific Biosciences Of California USD -40.37M 2.37M Dec/2025
Pharma Mar EUR 1.53M 58.13M Mar/2026
Qiagen NV USD 68.04M 39.79M Mar/2026
Quest Diagnostics USD 320M 69M Jun/2026
Quidel USD -91.8M 38.9M Mar/2026
Repligen USD 8.33M 4.95M Mar/2026
Revvity USD 40.72M 57.65M Mar/2026
Sartorius EUR 65.9M 9.7M Jun/2026
Sino Biopharmaceutical CNY 3.39B 2.91B Jun/2025
Thermo Fisher Scientific USD 1.74B 85M Jun/2026
Tilray USD -44.93M 44.61M Sep/2025
Waters USD -72M 297.21M Mar/2026
Zealand Pharma A/S -379.12M 25.12M Dec/2025
Zz Pientze Pharmaceu CNY 743.48M 56.45M Mar/2026